Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder
PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be associated with dysregulated growth, including height and BMI. The reason for this association is yet unknown. The objective of this study w...
Saved in:
Published in: | Growth hormone & IGF research Vol. 65; p. 101485 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
01-08-2022
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be associated with dysregulated growth, including height and BMI. The reason for this association is yet unknown. The objective of this study was to examine differences in growth hormone (GH) response to exercise between children who had received a diagnosis of ADHD and age- and gender-matched controls. We reasoned that the normal increase in circulating GH seen in response to exercise would be blunted in children with ADHD. METHODSWe recruited 13 treatment-naïve children with newly diagnosed ADHD and 14 age-matched controls (all male) and measured GH response to an exercise test in which the work was scaled to each subject's physical capability. RESULTSThere was no difference in the peak heart rate achieved during exercise between controls and ADHD participants (196.6 ± 1.5 vs. 196.5 ± 2.1 bpm, respectively) and lactate response to exercise (53.8 ± 5.0 vs. 47.9 ± 3.8 mg/dl, respectively). After exercise, GH increased significantly in the control subjects (p < 0.005), while GH responses were substantially blunted in the ADHD group (p = NS) even though the work performed did not differ from controls. CONCLUSIONSOur data suggest that GH excretion after exercise challenge in children with ADHD is impaired. This can be detected using a minimally invasive, nonpharmacologic challenge and may link ADHD with growth impairment in some children. TRIAL REGISTRATION NUMBERNCT00945971. |
---|---|
AbstractList | PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be associated with dysregulated growth, including height and BMI. The reason for this association is yet unknown. The objective of this study was to examine differences in growth hormone (GH) response to exercise between children who had received a diagnosis of ADHD and age- and gender-matched controls. We reasoned that the normal increase in circulating GH seen in response to exercise would be blunted in children with ADHD. METHODSWe recruited 13 treatment-naïve children with newly diagnosed ADHD and 14 age-matched controls (all male) and measured GH response to an exercise test in which the work was scaled to each subject's physical capability. RESULTSThere was no difference in the peak heart rate achieved during exercise between controls and ADHD participants (196.6 ± 1.5 vs. 196.5 ± 2.1 bpm, respectively) and lactate response to exercise (53.8 ± 5.0 vs. 47.9 ± 3.8 mg/dl, respectively). After exercise, GH increased significantly in the control subjects (p < 0.005), while GH responses were substantially blunted in the ADHD group (p = NS) even though the work performed did not differ from controls. CONCLUSIONSOur data suggest that GH excretion after exercise challenge in children with ADHD is impaired. This can be detected using a minimally invasive, nonpharmacologic challenge and may link ADHD with growth impairment in some children. TRIAL REGISTRATION NUMBERNCT00945971. |
ArticleNumber | 101485 |
Author | Nemet, Dan Eliakim, Roi A. Ben-Zaken, Sigal Eliakim, Alon |
Author_xml | – sequence: 1 givenname: Dan surname: Nemet fullname: Nemet, Dan – sequence: 2 givenname: Sigal surname: Ben-Zaken fullname: Ben-Zaken, Sigal – sequence: 3 givenname: Roi A. surname: Eliakim fullname: Eliakim, Roi A. – sequence: 4 givenname: Alon surname: Eliakim fullname: Eliakim, Alon |
BookMark | eNotkMtOwzAQRS1UJNrCD7Dykk2KH4njLFHFS0JCQrC2XHvSuErtYruU_j2Jwmpm7lzN1ZwFmvngAaFbSlaUUHG_W207F1eMMDYKpawu0JxWnBWMcTkbetKIQvC6vEKLlHaEkIbLco78B9ijAYvhF6JxCQrnJ2Ebwyl3uAtxP2ThBCZCdsFjPcxbbDrX2wgen9zg0jmDH7eFhdYZl3F3PkDUJrsfl8_YuhSihXiNLlvdJ7j5r0v09fT4uX4p3t6fX9cPb4VhkuRiQzQzFaGkbtsNNCWTVmrBGiZFO7xHq9pAyUohNpZTXZoGrK4pF4SIupYC-BLdTXcPMXwfIWW1d8lA32sP4ZgUE1JWjA8Bg5VNVhNDShFadYhur-NZUaJGuGqnRrhqhKsmuPwPMhdyaQ |
CitedBy_id | crossref_primary_10_1038_s41598_024_58009_7 crossref_primary_10_3389_fendo_2023_1163263 crossref_primary_10_1016_j_jaac_2023_03_015 crossref_primary_10_1038_s41390_023_02671_6 crossref_primary_10_1016_j_ghir_2024_101596 |
Cites_doi | 10.1249/00005768-198205000-00012 10.1016/S0022-3476(77)80788-9 10.1542/peds.111.5.1010 10.1016/j.neubiorev.2020.09.031 10.1203/01.PDR.0000061750.71168.23 10.12659/MSM.890495 10.1016/S0002-7138(09)60719-6 10.1152/japplphysiol.01072.2005 10.1177/0009922820902437 10.1097/PSY.0000000000000787 10.1542/peds.2014-0428 10.4088/JCP.13l08580 10.1203/00006450-199311000-00016 10.1097/00004583-199611000-00014 10.1111/jcpp.12684 10.1097/01.chi.0000235075.25038.5a 10.1016/0024-3205(84)90415-6 10.1123/pes.20.4.370 10.1016/0024-3205(87)90060-9 10.1542/peds.70.6.987 10.1046/j.1365-2265.2003.01847.x 10.1016/j.jpeds.2015.08.036 10.1530/eje.1.02186 10.3390/genes12091407 10.1210/clinem/dgab846 10.1097/00004583-199603000-00006 10.1016/j.neubiorev.2021.01.022 |
ContentType | Journal Article |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1016/j.ghir.2022.101485 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1532-2238 |
EndPage | 101485 |
ExternalDocumentID | 10_1016_j_ghir_2022_101485 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO AAYXX ABBQC ABGSF ABJNI ABMAC ABMZM ABUDA ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CITATION COF CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K Z5R ~G- 7X8 |
ID | FETCH-LOGICAL-c280t-b0a2c50107ffbe9428d8a629286f101157ce42466bd31a4c9eda71360067786e3 |
ISSN | 1096-6374 |
IngestDate | Sat Oct 05 06:25:18 EDT 2024 Thu Sep 26 15:41:56 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c280t-b0a2c50107ffbe9428d8a629286f101157ce42466bd31a4c9eda71360067786e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2688523107 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2688523107 crossref_primary_10_1016_j_ghir_2022_101485 |
PublicationCentury | 2000 |
PublicationDate | 2022-08-00 20220801 |
PublicationDateYYYYMMDD | 2022-08-01 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-00 |
PublicationDecade | 2020 |
PublicationTitle | Growth hormone & IGF research |
PublicationYear | 2022 |
References | De Zegher (10.1016/j.ghir.2022.101485_bb0070) 1993; 34 Pliszka (10.1016/j.ghir.2022.101485_bb0010) 1996; 35 Eliakim (10.1016/j.ghir.2022.101485_bb0110) 2008; 20 Borg (10.1016/j.ghir.2022.101485_bb0120) 1982; 14 Davallow Ghajar (10.1016/j.ghir.2022.101485_bb0015) 2020; 59 Swanson (10.1016/j.ghir.2022.101485_bb0030) 2017; 58 Kim (10.1016/j.ghir.2022.101485_bb0080) 2020; 31 Wigal (10.1016/j.ghir.2022.101485_bb0115) 2003; 53 Wittert (10.1016/j.ghir.2022.101485_bb0105) 2000 Loewen (10.1016/j.ghir.2022.101485_bb0145) 2020; 82 Eliakim (10.1016/j.ghir.2022.101485_bb0135) 2006; 100 Dmitrzak-Weglarz (10.1016/j.ghir.2022.101485_bb0140) 2021; 12 Biederman (10.1016/j.ghir.2022.101485_bb0025) 2003; 111 Trainer (10.1016/j.ghir.2022.101485_bb0125) 2006; 155 Hunt (10.1016/j.ghir.2022.101485_bb0090) 1984; 35 Rose (10.1016/j.ghir.2022.101485_bb0060) 2015; 167 Giordano (10.1016/j.ghir.2022.101485_bb0130) 2003; 59 Aarskog (10.1016/j.ghir.2022.101485_bb0085) 1977; 90 Schultz (10.1016/j.ghir.2022.101485_bb0095) 1982; 70 Harstad (10.1016/j.ghir.2022.101485_bb0035) 2014; 134 Greenhill (10.1016/j.ghir.2022.101485_bb0100) 1981; 20 Swanson (10.1016/j.ghir.2022.101485_bb0055) 2006; 45 Peyre (10.1016/j.ghir.2022.101485_bb0040) 2013; 74 Carucci (10.1016/j.ghir.2022.101485_bb0050) 2021; 120 Weizman (10.1016/j.ghir.2022.101485_bb0075) 1987; 40 Spencer (10.1016/j.ghir.2022.101485_bb0020) 1996; 35 Faraone (10.1016/j.ghir.2022.101485_bb0005) 2021; 128 Pinhas-Hamiel (10.1016/j.ghir.2022.101485_bb0045) 2022; 107 Ptacek (10.1016/j.ghir.2022.101485_bb0065) 2014; 20 |
References_xml | – volume: 14 start-page: 377 year: 1982 ident: 10.1016/j.ghir.2022.101485_bb0120 article-title: Psychophysical bases of perceived exertion publication-title: Med. Sci. Sports Exerc. doi: 10.1249/00005768-198205000-00012 contributor: fullname: Borg – volume: 90 start-page: 136 year: 1977 ident: 10.1016/j.ghir.2022.101485_bb0085 article-title: The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children publication-title: J. Pediatr. doi: 10.1016/S0022-3476(77)80788-9 contributor: fullname: Aarskog – volume: 111 start-page: 1010 year: 2003 ident: 10.1016/j.ghir.2022.101485_bb0025 article-title: Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment publication-title: Pediatrics doi: 10.1542/peds.111.5.1010 contributor: fullname: Biederman – volume: 120 start-page: 509 year: 2021 ident: 10.1016/j.ghir.2022.101485_bb0050 article-title: Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2020.09.031 contributor: fullname: Carucci – volume: 53 start-page: 756 year: 2003 ident: 10.1016/j.ghir.2022.101485_bb0115 article-title: Catecholamine response to exercise in children with attention deficit hyperactivity disorder publication-title: Pediatr. Res. doi: 10.1203/01.PDR.0000061750.71168.23 contributor: fullname: Wigal – volume: 20 start-page: 608 year: 2014 ident: 10.1016/j.ghir.2022.101485_bb0065 article-title: Disruptive patterns of eating behaviors and associated lifestyles in males with ADHD publication-title: Med. Sci. Monit. doi: 10.12659/MSM.890495 contributor: fullname: Ptacek – volume: 20 start-page: 84 year: 1981 ident: 10.1016/j.ghir.2022.101485_bb0100 article-title: Growth hormone, prolactin, and growth responses in hyperkinetic males treated with d-amphetamine publication-title: J Am Acad Child Psychiatry doi: 10.1016/S0002-7138(09)60719-6 contributor: fullname: Greenhill – volume: 100 start-page: 1630 year: 2006 ident: 10.1016/j.ghir.2022.101485_bb0135 article-title: Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents publication-title: J. Appl. Physiol. doi: 10.1152/japplphysiol.01072.2005 contributor: fullname: Eliakim – start-page: 43 year: 2000 ident: 10.1016/j.ghir.2022.101485_bb0105 contributor: fullname: Wittert – volume: 59 start-page: 401 year: 2020 ident: 10.1016/j.ghir.2022.101485_bb0015 article-title: Children with attention-deficit/hyperactivity disorder are at increased risk for slowed growth and short stature in early childhood publication-title: Clin. Pediatr. doi: 10.1177/0009922820902437 contributor: fullname: Davallow Ghajar – volume: 82 start-page: 305 year: 2020 ident: 10.1016/j.ghir.2022.101485_bb0145 article-title: Adherence to life-style recommendations and attention-deficit/hyperactivity disorder: a population-based study of children aged 10 to 11 years publication-title: Psychosom. Med. doi: 10.1097/PSY.0000000000000787 contributor: fullname: Loewen – volume: 134 start-page: e935 year: 2014 ident: 10.1016/j.ghir.2022.101485_bb0035 article-title: ADHD, stimulant treatment, and growth: a longitudinal study publication-title: Pediatrics doi: 10.1542/peds.2014-0428 contributor: fullname: Harstad – volume: 74 start-page: 1123 year: 2013 ident: 10.1016/j.ghir.2022.101485_bb0040 article-title: Long-term effects of ADHD medication on adult height: results from the NESARC publication-title: J Clin Psychiatry doi: 10.4088/JCP.13l08580 contributor: fullname: Peyre – volume: 34 start-page: 642 year: 1993 ident: 10.1016/j.ghir.2022.101485_bb0070 article-title: Dopamine inhibits growth hormone and prolactin secretion in the human newborn publication-title: Pediatr. Res. doi: 10.1203/00006450-199311000-00016 contributor: fullname: De Zegher – volume: 35 start-page: 1460 year: 1996 ident: 10.1016/j.ghir.2022.101485_bb0020 article-title: Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? publication-title: J. Am. Acad. Child Adolesc. Psychiatry doi: 10.1097/00004583-199611000-00014 contributor: fullname: Spencer – volume: 58 start-page: 663 year: 2017 ident: 10.1016/j.ghir.2022.101485_bb0030 article-title: Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression publication-title: J. Child Psychol. Psychiatry doi: 10.1111/jcpp.12684 contributor: fullname: Swanson – volume: 45 start-page: 1304 year: 2006 ident: 10.1016/j.ghir.2022.101485_bb0055 article-title: Stimulant-related reductions of growth rates in the PATS publication-title: J. Am. Acad. Child Adolesc. Psychiatry doi: 10.1097/01.chi.0000235075.25038.5a contributor: fullname: Swanson – volume: 35 start-page: 885 year: 1984 ident: 10.1016/j.ghir.2022.101485_bb0090 article-title: Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity publication-title: Life Sci. doi: 10.1016/0024-3205(84)90415-6 contributor: fullname: Hunt – volume: 20 start-page: 370 year: 2008 ident: 10.1016/j.ghir.2022.101485_bb0110 article-title: Exercise provocation test for growth hormone secretion: methodologic considerations publication-title: Pediatr. Exerc. Sci. doi: 10.1123/pes.20.4.370 contributor: fullname: Eliakim – volume: 40 start-page: 2247 year: 1987 ident: 10.1016/j.ghir.2022.101485_bb0075 article-title: Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity publication-title: Life Sci. doi: 10.1016/0024-3205(87)90060-9 contributor: fullname: Weizman – volume: 70 start-page: 987 year: 1982 ident: 10.1016/j.ghir.2022.101485_bb0095 article-title: Methylphenidate treatment of hyperactive children: effects on the hypothalamic-pituitary-somatomedin axis publication-title: Pediatrics doi: 10.1542/peds.70.6.987 contributor: fullname: Schultz – volume: 59 start-page: 314 year: 2003 ident: 10.1016/j.ghir.2022.101485_bb0130 article-title: Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans publication-title: Clin. Endocrinol. doi: 10.1046/j.1365-2265.2003.01847.x contributor: fullname: Giordano – volume: 167 start-page: 1389 year: 2015 ident: 10.1016/j.ghir.2022.101485_bb0060 article-title: Attention-deficit/hyperactivity disorder medication treatment impact on response to growth hormone therapy: results from the ANSWER program, a non-interventional study publication-title: J. Pediatr. doi: 10.1016/j.jpeds.2015.08.036 contributor: fullname: Rose – volume: 155 start-page: 1 year: 2006 ident: 10.1016/j.ghir.2022.101485_bb0125 article-title: Consensus statement on the standardisation of GH assays publication-title: Eur. J. Endocrinol. doi: 10.1530/eje.1.02186 contributor: fullname: Trainer – volume: 12 year: 2021 ident: 10.1016/j.ghir.2022.101485_bb0140 article-title: Common and unique genetic background between attention-deficit/hyperactivity disorder and excessive body weight publication-title: Genes (Basel) doi: 10.3390/genes12091407 contributor: fullname: Dmitrzak-Weglarz – volume: 31 start-page: 154 year: 2020 ident: 10.1016/j.ghir.2022.101485_bb0080 article-title: Preliminary investigation of association between methylphenidate and serum growth markers in children with attention-deficit/hyperactivity disorder: a cross-sectional case-control study publication-title: Soa Chongsonyon Chongsin Uihak contributor: fullname: Kim – volume: 107 start-page: e1434 year: 2022 ident: 10.1016/j.ghir.2022.101485_bb0045 article-title: Attention-deficit/hyperactivity disorder and obesity: a National Study of 1.1 million Israeli adolescents publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/clinem/dgab846 contributor: fullname: Pinhas-Hamiel – volume: 35 start-page: 264 year: 1996 ident: 10.1016/j.ghir.2022.101485_bb0010 article-title: Catecholamines in attention-deficit hyperactivity disorder: current perspectives publication-title: J. Am. Acad. Child Adolesc. Psychiatry doi: 10.1097/00004583-199603000-00006 contributor: fullname: Pliszka – volume: 128 start-page: 789 year: 2021 ident: 10.1016/j.ghir.2022.101485_bb0005 article-title: The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2021.01.022 contributor: fullname: Faraone |
SSID | ssj0009384 |
Score | 2.3845825 |
Snippet | PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 101485 |
Title | Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder |
URI | https://search.proquest.com/docview/2688523107 |
Volume | 65 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9tAEF4cB0ovpU1amrYJWwi9iA3SSlqtj24j50GaQuOA6UWstSvbecillg-F_vjOPmRJySU99CLMIMli5mN2ZnfmG4QOA8n9XLKYDHhQkEgyn2hWKwJLvxC-Xwga6Obk06vkcsKP0yjt9f7UWf9G9l8tDTKwte6c_Qdrb14KAvgNNocrWB2uT7L7d83FClFkPUuJQNJtBDNIuKu5N4cgdQmR5UrHi3ZMuJk31Onq9jTrpqmDJFJpjonKm0PCajqqzLAJ6Ug727HtSfcPNKbOTkaeoxNqbTvf2wOQ4waYn1VJfohb6wKvFjOxqftI7xYQ49pZzMtFs_Pakg_vHLTc5gXkvXXpHKw9tcOlBEIU3vbILG65VD1M2E71cQt0I3jk_u1OxM3RbL7QXK-UHrWfbnNtX37LRtcXF9k4nYy30DYFNxX30fbwLJ2cN6TNIY9co5WtCXz43m4w013LTYAyfoleuMwCDy0kXqGeKnfQ7rAU1fL-N_6ETa2vOUTZQc--upKKXVQ6wOCHgMEWMNjZE28Agw1gcA0YrAGDHwEGdwCDa8C8RtejdPzllLghHCSn3K_I1Bc0jyFrT4piqgaQrUouGB1QzopA5xNJriIaMTaVYSCifKCkSIKQ-ZaaUIVvUL-Er3yLsPBFLmVeFLq7MleCywgeiqiE26Jwmu8hr9Zm9tNyrWR1EeJNpnWfad1nVvd76GOt8Axcoj7nEqVarlcZZZzHOm9J3j3hnvfoeYPMD6hf_VqrfbS1kusDh4e_pK2GSw |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+exercise-induced+growth+hormone+secretion+among+children+with+attention-deficit+hyperactivity+disorder&rft.jtitle=Growth+hormone+%26+IGF+research&rft.au=Nemet%2C+Dan&rft.au=Ben-Zaken%2C+Sigal&rft.au=Eliakim%2C+Roi+A&rft.au=Eliakim%2C+Alon&rft.date=2022-08-01&rft.eissn=1532-2238&rft.volume=65&rft.spage=101485&rft.epage=101485&rft_id=info:doi/10.1016%2Fj.ghir.2022.101485&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6374&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6374&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6374&client=summon |